Determining the Impact of CAT Score in Chronic Obstructive Pulmonary Diseases Patients Health in Our Region
COPD is a condition that causes a great deal of misery in people. It is increasingly recognised as a widespread disease in developing countries, and it is one of the leading causes of death. Although pulmonary function tests are critical for diagnosing and assessing the severity of COPD, other functional status indicators such as dyspnoea, exercise performance, and health status are crucial aspects of the disease that cannot be assessed using this method. The COPD assessment test (CAT) is a new eight-item questionnaire designed to provide a quick, easy, and self-administered exam for evaluating symptoms and determining the impact of COPD on health status (Quality Of Life). This study demonstrates the utility of the CAT score in our location. The current study’s clinical features, Gold Severity, and FEVI 1 percent were compared to previous studies from various nations. Between May and September 2014, a total of 70 COPD patients were investigated. A thorough clinical history was gathered. The CAT questionnaire was used to determine the severity of the symptoms. Pulmonary function tests (before and post bronchodilator therapy) and oxygen saturation measurements were performed on them. The majority of the patients were 42-year-old men (60 percent ). A total of 41 patients (58.6%) were smokers, with 36 (87.80%) being men. 18 patients (25.7%) had a positive history of Chula exposure, with 17 (94.44%) being females. Patients had a mean age of 60.34 SD 9.9, a mean FEV1 of 62.33 SD 18.2, and a mean SPO2 of 94.26 SD 2.27. Two groups of patients were identified. Group 1 has low symptoms and has a CAT Score of 10; group 2 has high symptoms and has a CAT Score of 10. Patients in Group 2 have a CAT score of greater than 10. Eighty percent of the patients had a high CAT score of >10 in Group 2. The majority of the patients (50%) had mild blockage. Patients whose projected forced expiratory volume in one second (FEV1%) was significantly lower had a significantly higher CAT score (t = 2.67, p=.009). Patients with advanced disease (as defined by the GOLD criteria) had a higher CAT score, indicating a positive correlation, but CAT score and FEVI percent had an inverse correlation. The mean FEV1 percent anticipated was similar to that of France, which was higher than Germany, the Netherlands, Spain, and the United States of America, but lower than Belgium. As a simple and accurate instrument, the CAT questionnaire shows to be a sensitive test in assessing COPD health status. Patients’ and clinicians’ awareness of COPD would be improved with the help of the CAT questionnaire, allowing for an early diagnosis and providing a useful and objective tool for early recognition and long-term clinical and therapeutic monitoring of COPD patients, particularly in clinical settings where spirometry is not yet available.
- COPD Assessment TEST (CAT) for determining the influence on COPD health status (Quality Of Life) in our region.
- The utility of CAT score in monitoring one’s health.
• Clinical characteristics of the current study compared to previous studies from other countries
Author (S) Details
Sumer Sanjiv Choudhary
Department of Pulmonary Medicine, NKP Salve Institute of Medical Sciences and Lata Mangeshkar Hospital, Nagpur, India and Department of Pulmonary Medicine, Shree Ramjeevan Choudhary Memorial Hospital and Research Centre, Nagpur, India.
View Book :- https://stm.bookpi.org/NFMMR-V8/article/view/3104